Bioequivalence Study of Montelukast, 5 mg Chewable Tablets (Pharmtechnology LLC, Belarus), and Singulair ®, 5 mg Chewable Tablets (Merck Sharp & Dohme B.V., the Netherlands), in Healthy Volunteers Under Fasting Conditions

Condition:   Healthy Adults Interventions:   Drug: Montelukast;   Drug: Singulair Sponsors:   Pharmtechnology LLC;   ClinPharmInvest, LLC Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials